One of the main aims of this study was to examine whether the CTLA-4 molecule is able to influence the expression of the key regulators of G0/G1 phase in CLL cells as well as normal B lymphocytes. Here, CTLA4 is linked to B-cell chronic lymphocytic leukemia.